BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Non-Current Debt (2017 - 2026)

Updated

BioLineRx (BLRX) reported Non-Current Debt of $2.22 million for the quarter ended Jun 30, 2026, down 67.0% from $6.72 million a year earlier and down 33.9% from the prior quarter.

Analysis

BioLineRx (BLRX) Non-Current Debt (2017 - 2026) Analysis & Trends

As of Dec 31, 2025, BioLineRx posted Non-Current Debt of $4.46 million, down 50.2% from the prior year.

  • Non-Current Debt has a five-year compound annual growth rate of 10.2% (years ended Dec 2020 to Dec 2025).
  • By year, Non-Current Debt came in at $8.96 million in the year ended Dec 31, 2024 (+35.2%), $6.63 million in the year ended Dec 31, 2023 (-23.2%) and $8.63 million in the year ended Dec 31, 2022.
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Non-Current Debt since the quarter ended Jun 30, 2021.
  • Year over year, Non-Current Debt has now declined in each of the last five quarters, with an average decline of 16.2% over the last eight quarters.
  • The high point for year-over-year Non-Current Debt in five years was the quarter ended Jun 30, 2024 (growth of 121.2%); the low point was the quarter ended Sep 30, 2025 (a decline of 68.9%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $3.36 million (quarter ended Mar 31, 2026), $4.46 million (quarter ended Dec 31, 2025) and $5.6 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00 2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.22 Mn
Mar 31, 2026 3.36 Mn
Dec 31, 2025 4.46 Mn
Sep 30, 2025 5.60 Mn
Jun 30, 2025 6.72 Mn
Mar 31, 2025 7.63 Mn
Dec 31, 2024 8.96 Mn
Sep 30, 2024 17.98 Mn
Jun 30, 2024 18.79 Mn
Mar 31, 2024 5.94 Mn
Dec 31, 2023 6.63 Mn
Sep 30, 2023 8.46 Mn
Jun 30, 2023 8.50 Mn
Mar 31, 2023 8.24 Mn
Dec 31, 2022 8.63 Mn
Sep 30, 2022 8.35 Mn
Jun 30, 2021 1.01 Mn
Mar 31, 2021 1.89 Mn
Dec 31, 2020 2.74 Mn
Sep 30, 2020 3.55 Mn
API Access

BioLineRx Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BLRX&period=max&api_key=YOUR_API_KEY